@paulromzek_gmt's 'blast GH' advice, fact-checked
Quick answer
Growth hormone is FDA-approved only for documented adult growth hormone deficiency, affecting fewer than 1 in 10,000 people. Supraphysiologic doses cause insulin resistance, joint problems, and potential long-term cardiovascular complications. Modest muscle mass increases (8-9% in studies) don't justify the substantial risks and costs for healthy individuals.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What does this video actually claim?
Paul Romzek's Instagram post tells followers to "be a man, blast GH" (growth hormone). While the post is brief, the message is clear: he's promoting high-dose growth hormone use as a masculine enhancement strategy.
The post includes promotion for coaching services and a research peptides company (Helixresearch.io). It's tagged with #trt and #biohacking, suggesting this advice sits within his broader hormone optimization content.
There's no medical context provided. No discussion of deficiency states, medical supervision, or potential risks.
Does growth hormone "blasting" actually work?
Growth hormone does increase lean body mass, but the effects aren't as dramatic as many influencers suggest. The important study by Rudman et al. (NEJM, 1990) found 8.8% increase in lean body mass over 6 months in elderly men with low IGF-1.
More recent data is less impressive. Blackman et al. (JAMA, 2002) studied GH in 131 healthy older adults and found modest increases in lean mass but no improvement in strength or functional capacity.
For younger, healthy men (Romzek's likely audience), benefits are even more questionable. Most studies showing meaningful effects use supraphysiologic doses that come with serious side effects.
What are the actual risks of "blasting" GH?
Romzek completely ignores the substantial risk profile of high-dose growth hormone use. Joint pain occurs in 20-30% of users even at therapeutic doses, according to multiple clinical trials.
More concerning are the metabolic effects. GH causes insulin resistance, with fasting glucose rising 10-15% in most studies. The French SAGhE study (Journal of Clinical Endocrinology, 2012) found increased mortality risk in patients who received higher GH doses as children.
Acromegaly-like symptoms develop with chronic supraphysiologic use. These include joint enlargement, sleep apnea, and cardiovascular complications that can be irreversible.
There's also the cancer question. IGF-1 levels correlate with prostate and colorectal cancer risk in multiple epidemiological studies, though causation isn't proven.
What's the legal and practical reality?
Growth hormone is a prescription medication requiring documented deficiency for legal use in the US. Adult GH deficiency affects fewer than 1 in 10,000 people, according to endocrinology guidelines.
Real pharmaceutical GH costs $1,000-3,000 monthly. Most "research peptides" marketed online are either fake, underdosed, or contaminated. The FDA doesn't regulate these products.
Legitimate TRT (which Romzek also promotes) has much better risk-benefit data for men with clinically low testosterone. But that's not what this post is about.
What should you actually know about GH?
Growth hormone isn't a magic masculinity enhancer. The modest muscle gains seen in studies come with real health risks and enormous costs.
If you're concerned about low energy, poor recovery, or muscle loss, get proper blood work done. Thyroid dysfunction, sleep disorders, and yes, clinically low testosterone are much more common and treatable causes.
Romzek's advice to "blast GH" without medical context is irresponsible. Real hormone optimization starts with addressing lifestyle factors and treating actual deficiencies, not chasing supraphysiologic levels of expensive hormones.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 6 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For @paulromzek_gmt's 'blast GH' advice, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Ipamorelin, the first selective growth hormone secretagogue
Background source for ipamorelin selectivity and GH-secretagogue mechanism.
PubMed
The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation
Preclinical context that should not be overstated as consumer clinical evidence.
PubMed
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
Video claim decision path
Turn the claim into a safer next question
Direct answer
@paulromzek_gmt's 'blast GH' advice, fact-checked should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.
Evidence check
Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.
Safety check
A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.
Next step
Use the health tools and supporting evidence to prepare questions for your clinician.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
Growth hormone is FDA-approved only for documented adult growth hormone deficiency, affecting fewer than 1 in 10,000 people.
FormBlends verdict
Growth hormone is FDA-approved only for documented adult growth hormone deficiency, affecting fewer than 1 in 10,000 people. Supraphysiologic doses cause insulin resistance, joint problems, and potential long-term cardiovascular complications. Modest muscle mass increases (8-9% in studies) don't justify the substantial risks and costs for healthy individuals.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Growth hormone is FDA-approved only for documented adult growth hormone deficiency, affecting fewer than 1 in 10,000 people. Supraphysiologic doses cause insulin resistance, joint problems, and potential long-term cardiovascular complications. Modest muscle mass increases (8-9% in studies) don't justify the substantial risks and costs for healthy individuals.
- Growth hormone increased lean mass by 8.8% in the landmark Rudman study, but most participants experienced joint pain and other side effects
- Pharmaceutical GH costs $1,000-3,000 monthly and requires a prescription for documented deficiency in the US
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Growth hormone increased lean mass by 8.8% in the landmark Rudman study, but most participants experienced joint pain and other side effects
- Pharmaceutical GH costs $1,000-3,000 monthly and requires a prescription for documented deficiency in the US
- High-dose GH causes insulin resistance, with fasting glucose rising 10-15% in clinical trials
- Adult GH deficiency affects fewer than 1 in 10,000 people according to endocrinology guidelines
- Most online 'research peptides' are unregulated and potentially contaminated or fake
- Joint pain occurs in 20-30% of GH users even at therapeutic doses
- The SAGhE study linked higher childhood GH doses to increased mortality risk in adulthood
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Paul Romzek | Online Coach · Instagram creator
39.1K views on this video
be a man, blast GH 📲 For coaching and consultation inquiries DM or email Paul@GreyMatter.Training 🧬 Helixresearch.io code ROMZEK #trt #biohacking
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Paul Romzek | Online Coach, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.